Daily Markup

Daily Markup #1029: Prenetics scores football legend David Beckham as strategic investor and co-founding partner of new health & wellness brand IM8

July 15, 2024 · 2 min read
Photo credit: Prenetics

A new era of healthcare beckons

  • Science and sports come together in this serendipitous partnership between 500-backed biotech company Prenetics and football legend, entrepreneur, and philanthropist David Beckham.
  • David is now a strategic investor in the company, and together they will be co-founding partners of IM8, a health and wellness brand for cutting-edge health products.
  • After connecting with Prenetics Co-founder & CEO Danny Yeung and shareholder Professor Dennis Lo, David was keen to find ways to partner with them after learning about Prof. Lo’s pioneering discovery of non-invasive prenatal testing in 1997 and current focus on early cancer detection.
  • Danny shared that IM8 is inspired by the desire to merge cutting-edge science with everyday health solutions. They aim to make advanced health solutions more accessible and relatable, as well as build trust and foster a community around health and wellness.
  • He added that IM8 will empower people with the right tools and knowledge to improve health outcomes and promote proactive health management.
  • David shared, “Throughout my life and career, I’ve been fortunate to have access to the best medical professionals, nutrition experts and fitness coaches. Their guidance has been crucial to my health and well-being. That’s why I am excited to be working with Prenetics—a company that is dedicated to innovative, world-leading scientific advancements in health—as a co-founding partner and ambassador for IM8.”
  • Read the full story on Tatler.
Daily
Tags:
0
Share
• • • KEEP READING

Daily Markup

  • Daily Markup is brought to you by 500 Global, Southeast Asia

  • All content herein is intended solely for general informational or educational purposes only. 500 Startups Management Company, L.L.C. and its affiliates (collectively “500 Global”) makes no representation as to the accuracy or information in this post and while reasonable steps have been taken to ensure that the information herein is accurate and up-to-date, no liability can be accepted for any error or omissions. All third party links in this post have not been independently verified by 500 Global and the inclusion of such links should not be interpreted as an endorsement or confirmation of the content within. Information about portfolio companies’ markets, competitors, performance, and fundraising has been provided by those companies’ founders and has not been independently verified. Under no circumstances should any content in this post be construed as investment, legal, tax or accounting advice by 500 Global, or an offer to provide any investment advisory service with regard to securities by 500 Global. No content or information in this post should be construed as an offer to sell or solicitation of interest to purchase any securities advised by 500 Global. Prospective investors considering an investment into any 500 Global fund should not consider or construe this content as fund marketing material. The views expressed herein are as at the date of this post and are subject to change without notice. One or more 500 Global fund may have a financial interest in one or more of the companies discussed

    All users of this website should note these important Terms of Use governing the use of this website.

  • Copyright © 2024 500 Global | All Rights Reserved

  • Privacy Policy
    Terms of Use
    Code of Conduct